Xu found a negative correlation between serum FGF21 content and PINP in patients with diabetic nephropathy through a cross-sectional study, suggesting that FGF21 may have a certain negative regulatory effect on bone formation (21). This evidence concerns the gene FGF21 and diabetic kidney disease.